India to Launch First Indigenous H5N1 Chicken Vaccine on November 20

Union Minister Shivraj Singh Chouhan will unveil the country's first indigenous H5N1 vaccine, developed to combat avian influenza, on November 20, 2026.

A
Aapla Nagpur Desk
18 Nov 2026, 9:38 AM IST · 2 min read
Source: PIB
India to Launch First Indigenous H5N1 Chicken Vaccine on November 20
KEY TAKEAWAYS
1

The vaccine targets the H5N1 Clade 2.3.2.1a strain, crucial for poultry health.

2

Bird flu outbreaks have historically caused significant economic losses in India.

3

The indigenous vaccine aims to protect poultry and mitigate public health risks.

On November 20, 2026, Union Minister of Agriculture and Farmers Welfare, Shri Shivraj Singh Chouhan, will inaugurate India's first indigenous inactivated H5N1 vaccine for chickens at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal. This vaccine represents a significant advancement in the country's efforts to combat Highly Pathogenic Avian Influenza (HPAI), specifically targeting the Clade 2.3.2.1a strain of the virus.

The emergence of HPAI, commonly referred to as bird flu, poses a grave threat to poultry, with outbreaks leading to nearly total mortality in affected birds. Since its first detection in India in 2006, the country has faced over 500 outbreaks of H5N1 and H5N8 subtypes, resulting in substantial economic repercussions for poultry farmers due to mass culling and trade restrictions. The potential impact of a major outbreak could decrease India's GDP growth by as much as 1.5%, with over 20% of the poultry population at risk if the virus spreads unchecked.

The financial toll of bird flu is staggering; the 2006 outbreak alone incurred estimated losses ranging from Rs. 2,200 to 3,000 crore. Additionally, outbreaks in states like Manipur have led to losses equivalent to 0.5% of the state's GDP. Beyond economic implications, the disease also poses a public health risk, with the World Health Organization reporting 1,003 human cases of H5N1 avian influenza and 479 fatalities across 25 countries since 2003.

The H5N1 Clade 2.3.2.1a strain has been the primary cause of bird flu outbreaks in chickens and has recently been detected in various animal species, including mammals. This underscores the urgency of controlling the virus's spread to protect both poultry farmers' livelihoods and public health. Currently, there is no commercial vaccine available for this specific strain, making the development of an indigenous vaccine critical for India.

The vaccine created by ICAR-NIHSAD is designed to provide essential protection against the circulating H5N1 virus strains, addressing a significant gap in the country's poultry health management. As the launch date approaches, stakeholders in the poultry industry and public health sectors are keenly anticipating the potential benefits of this innovative vaccine.

💬What did you think of this story?What did you think?

Read Next

India's First Indigenous H5N1 Vaccine Launch